Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products.
As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.
We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.
Company Details
- Employees
- 173
- Founded
- -
- Address
- Fraunhoferstr. 18 B, Martinsried (Munich),bavaria 82152,germany
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- coriolis-pharma.com
- HQ
- Martinsried (Munich), Bavaria
Coriolis Pharma Questions
Coriolis Pharma's website is coriolis-pharma.com
Coriolis Pharma's LinkedIn profile is https://de.linkedin.com/company/coriolis-pharma
Coriolis Pharma has
173 employees.
View email and phone details for 173
employees at Coriolis Pharma.
Coriolis Pharma's industry is
Pharmaceutical Manufacturing
Coriolis Pharma's top competitors are
Roche,
Boehringer Ingelheim,
Eisbach Bio Gmbh,
Proteros Biostructures Gmbh,
Formycon Ag,
Iomx Therapeutics Ag,
Medigene Ag,
Daiichi Sankyo Europe Gmbh,
Morphosys,
Leukocare Ag.
Coriolis Pharma's categories are Pharmaceutical Manufacturing
Coriolis Pharma's founding year is 2008
